Ad
related to: pfizer 2023 results live
Search results
Results From The WOW.Com Content Network
Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. ... NFL Black Monday live updates: Latest rumors, news ...
The updated Covid vaccines should be more accessible, experts say. Saturday 16 September 2023 21:00, Maggie O’Neill. The cost of the new Covid vaccines may prohibit some people from getting them ...
In September 2023, the FDA approved an updated monovalent (single) component Omicron variant XBB.1.5 version of the vaccine (Comirnaty 2023–2024 formula) as a single dose for individuals aged twelve years of age and older; [30] and authorized the Pfizer-BioNTech COVID-19 Vaccine 2023–2024 formula under emergency use for individuals aged 6 ...
The drugmaker said it now expects 2023 revenue of between $58 billion and $61 billion, down from it prior forecast of $67 billion to $70 billion. It said the reduction was solely due to lowered ...
Pfizer is due to report its third-quarter earnings on Nov. 1. Julie Hyman is the co-anchor of Yahoo Finance Live, weekdays 9am-11am ET . Follow her on Twitter @juleshyman , and read her other stories.
In August 2022, Pfizer and Valneva initiated the currently ongoing Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524), to investigate the efficacy, safety and immunogenicity of VLA15 in participants five years of age and older in highly endemic regions in the United States (U.S.) and Europe. 3 The ...
Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]
COVID-19 gave a shot in the arm to Pfizer's sales and culture. Now CEO Albert Bourla lays out a plan to replace vaccine revenue as the virus' impact wanes. Pfizer CEO: 2023 will be a 'pivotal year ...